Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

84.3K
Overview
84.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
What is the Immune System?01:38

What is the Immune System?

132.4K
Overview
132.4K
Humoral Immune Responses01:36

Humoral Immune Responses

84.1K
Overview
84.1K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

111.4K
Overview
111.4K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

11.9K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers.

Annals of the rheumatic diseases·2026
Same author

A skeletal muscle atlas shows neuromuscular junction adaptations to growth and atrophy.

Developmental cell·2026
Same author

Brachio-cervical inflammatory myopathy: multilevel clinical, histopathological and multi-omic analyses of a syndrome variably associated with systemic sclerosis.

Acta neuropathologica·2026
Same author

Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositis.

Seminars in arthritis and rheumatism·2026
Same author

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Recurrent and new primary cancer risk in adult patients with idiopathic inflammatory myositis and a history of malignancy.

Clinical and experimental rheumatology·2026

Related Experiment Video

Updated: Feb 12, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.5K

Immune-Mediated Necrotizing Myopathy.

Iago Pinal-Fernandez1,2, Maria Casal-Dominguez3,4, Andrew L Mammen5,6,7

  • 1Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Expression, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1146, Building 50, MSC 8024, Bethesda, MD, 20892, USA. iago.pinalfernandez@nih.gov.

Current Rheumatology Reports
|March 28, 2018
PubMed
Summary
This summary is machine-generated.

Immune-mediated necrotizing myopathy (IMNM) involves distinct subtypes based on autoantibodies. Early immunosuppression is crucial for preventing long-term disability in IMNM patients.

Keywords:
AutoantibodiesHMGCR protein, humanMyositisNecrotizing myositisPolymyositisSignal recognition particle

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.1K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K

Related Experiment Videos

Last Updated: Feb 12, 2026

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.5K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.1K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.0K

Area of Science:

  • Neurology
  • Immunology
  • Muscle Diseases

Background:

  • Immune-mediated necrotizing myopathy (IMNM) is an autoimmune disorder causing severe muscle weakness.
  • It is characterized by muscle fiber necrosis with minimal inflammation on biopsy.

Purpose of the Study:

  • To review the characteristics of patients diagnosed with IMNM.
  • To differentiate between IMNM subtypes based on autoantibody presence.

Main Methods:

  • Review of patient characteristics associated with IMNM.
  • Classification of IMNM into anti-SRP, anti-HMGCR, and autoantibody-negative subtypes.

Main Results:

  • Anti-signal recognition particle (SRP) and anti-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) autoantibodies define distinct IMNM subtypes.
  • Anti-SRP myopathy often presents with more severe muscle and extra-muscular involvement.
  • Anti-HMGCR myopathy is linked to statin use, and both subtypes are severe in younger patients, potentially reversible with early treatment.

Conclusions:

  • IMNM comprises anti-SRP, anti-HMGCR, and autoantibody-negative forms.
  • Early and aggressive immunosuppressive therapy is recommended to prevent irreversible muscle damage.
  • Distinct subtypes of IMNM require tailored treatment strategies.